Dear Editor, We read with interest the study by Elias et al. who retrospectively investigated the utility of a combined GnRH-agonist (GnRHa) and human chorionic gonadotropin (hCG) trigger (Bdual trigger^) in improving ICSI cycle outcomes in patients with poor fertilization history after standard hCG trigger in prior ICSI cycles [1] . BDual trigger^was found to increase oocyte maturity, fertilization, clinical pregnancy, and livebirth rates in patients with a history of poor fertilization after standard hCG trigger alone.
While they thoroughly covered the conceptual and practical aspects of the Bdual trigger,^we still would like to highlight several points that went unnoticed. Nowadays, different modes and timing of GnRHa combined with hCG trigger, for final follicular maturation, have been described [2] .
A modification of the Bdual trigger,^the so-called double trigger approach, has been successfully used in a patient with recurrent empty follicle syndrome [3] . The Bdouble trigger,ŵ hich consists of the co-administration of GnRH-agonist and hCG for final oocyte maturation, 40 and 34 h prior to ovum pick-up (OPU), respectively, differs from the Bdual trigger^by the additional prolongation of the time between ovulation triggering and OPU. This later prolongation may explain the beneficial effect in terms of both oocytes yield/maturation and pregnancy rate.
The Bdouble trigger^was also shown to significantly improve the oocyte yield in patients with low/poor oocytes yield, despite an apparently normal follicular development and E2 levels on the day of hCG administration [4] and increase the proportions of metaphase-II (MII) oocytes in patients with low proportion of mature oocytes per number oocytes retrieved [5] .
We recently suggested to tailor final-follicularmaturation trigger [6] . We offer standard hCG dose concomitant with GnRHa (Bdual trigger^) 35-37 h before oocyte retrieval to normal-responder patients, aiming to improve oocytes yield, number of matured oocytes, and top-quality and cryopreserved embryos. GnRHa 40 h and standard hCG added 34 h prior to OPU (double trigger), respectively, are offered to two groups of patients demonstrating abnormal final follicular maturation despite normal response to COH, those with low (<50%) number of oocytes retrieved per number of dominant follicles >14 mm in diameter on the day of hCG administration and those with low proportion of mature/ metaphase-II (MII) oocytes (<66%) per number oocytes retrieved. Finally, standard hCG dose concomitant with GnRHa (Bdual trigger^), 34 h before oocyte retrieval was offered to poor-responder patients, aiming to improve oocytes yield and maturation and prevent premature luteinization.
